Common Contracts
1 similar Participant Information and Agreement contracts
PARTICIPANT INFORMATION AND AGREEMENT TO TAKE PART FORMParticipant Information and Agreement • October 7th, 2019
Administrative information: Universal trial number: U1111-1218-5368 EudraCT number/IND number: 2018-003141-42 Version: US_6.0 Official name of the study: Semaglutide cardiovascular outcomes trial in patients with type 2 diabetes (SOUL) Research sponsor contact information: Novo Nordisk A/S, Novo Allé, 2880 Bagsvaerd, Denmark A description of this clinical trial will be available on http://www.ClinicalTrials.gov, as required byU.S. Law. This Web site will not include information that can identify you. At most, the Web site will include a summary of the results. You can search this Web site at any time. Information about the study and the results will also be made available at www.novonordisk- trials.com and www.clinicaltrialsregister.eu.
